Martin_1997_Eur.J.Anaesthesiol_14_467

Reference

Title : Physostigmine: going ... going ... gone? Two cases of central anticholinergic syndrome following anaesthesia and its treatment with physostigmine - Martin_1997_Eur.J.Anaesthesiol_14_467
Author(s) : Martin B , Howell PR
Ref : European Journal of Anaesthesiology , 14 :467 , 1997
Abstract :

Two patients presented with very different signs of central anticholinergic syndrome following general anaesthesia for which they had received premedication with hyoscine. Both responded dramatically to 1 mg of intravenous (i.v.) physostigmine, which produced a rapid return to a normal level of consciousness. The aetiology of central anticholinergic syndrome is multi-factorial, but the diagnosis should be considered in all patients who demonstrate abnormal post-anaesthetic awakening. It is recommended that 1 mg of intravenous physostigmine is a safe and effective treatment for central anticholinergic syndrome, and that a supply of this important drug must be kept readily available in the recovery area of the operating theatre department.

PubMedSearch : Martin_1997_Eur.J.Anaesthesiol_14_467
PubMedID: 9253580

Related information

Citations formats

Martin B, Howell PR (1997)
Physostigmine: going ... going ... gone? Two cases of central anticholinergic syndrome following anaesthesia and its treatment with physostigmine
European Journal of Anaesthesiology 14 :467

Martin B, Howell PR (1997)
European Journal of Anaesthesiology 14 :467